Joel Beatty
Stock Analyst at Baird
(1.62)
# 1379
Out of 5,270 analysts
258
Total ratings
37.59%
Success rate
15.31%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Praxis Precision Med... | Maintains: Outperform | 117 73 | 33.79 | 116.04% | 2 | Mar 3, 2025 | |
Catalyst Pharmaceuti... | Maintains: Outperform | 28 32 | 22.32 | 43.37% | 2 | Mar 3, 2025 | |
Axsome Therapeutics | Maintains: Outperform | 132 160 | 127.09 | 25.9% | 4 | Mar 3, 2025 | |
Cogent Biosciences | Maintains: Neutral | 10 8 | 7.04 | 13.64% | 4 | Feb 27, 2025 | |
Denali Therapeutics | Initiates Coverage On: Outperform | 31 | 15.12 | 105.03% | 1 | Jan 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 10 8 | 1.77 | 351.98% | 3 | Dec 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 52 70 | 52.75 | 32.7% | 14 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 75 | 35.34 | 112.22% | 1 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 154 162 | 140.19 | 15.56% | 3 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 3 11 | 3.06 | 259.48% | 4 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 7 | 1.86 | 276.34% | 5 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 54 72 | 16.34 | 340.64% | 2 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 515 650 | 622.66 | 4.39% | 5 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 72 65 | 71.05 | -8.52% | 5 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 32 | 6.63 | 382.65% | 1 | Oct 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 240 175 | 63.97 | 173.57% | 4 | Oct 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 13 9 | 7.21 | 24.83% | 4 | Oct 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 16 | 2.64 | 506.06% | 1 | Sep 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 112 127 | 89.66 | 41.65% | 3 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 58 | 19.64 | 195.32% | 1 | Jul 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 37 38 | 34.1 | 11.44% | 2 | Jul 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 60 | n/a | n/a | 2 | Jul 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 68 72 | 41.14 | 75.01% | 4 | May 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 27 | 6.07 | 344.81% | 1 | May 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 20 | 0.73 | 2639.73% | 3 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 28 | 18.14 | 54.36% | 3 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 5 | 1.72 | 161.63% | 2 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 103 | 131.27 | -21.54% | 2 | Apr 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 25 | 14.16 | 76.55% | 3 | Apr 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 11 9 | 0.42 | 2042.86% | 2 | Mar 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | n/a | n/a | 3 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 28 | 15.56 | 79.95% | 2 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | n/a | n/a | 1 | Sep 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 60 | 0.03 | 199900% | 3 | Aug 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 16 | 7.78 | 105.66% | 1 | Jun 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | 5.08 | 37.8% | 1 | May 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 2 | 1.69 | -26.04% | 2 | May 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 44 | 1.4 | 3042.86% | 3 | Apr 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 58 | 17.72 | 227.31% | 6 | Feb 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 24 | 19.09 | 25.72% | 2 | Nov 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 18 | 15.72 | 14.5% | 3 | Nov 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 6 | 3.83 | 56.66% | 2 | Aug 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 46 31 | 1.26 | 2360.32% | 3 | Jun 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 36 28 | 7.89 | 254.88% | 2 | Mar 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 170 175 | 243.64 | -28.17% | 2 | Feb 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 | 4.69 | 198.51% | 8 | Jan 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 108 | 101.19 | 6.73% | 7 | Jan 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 74 | n/a | n/a | 2 | Oct 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 78 | 32.54 | 139.7% | 3 | Aug 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 440 160 | n/a | n/a | 2 | Jun 11, 2020 |